JiangXi Tianxin Pharmaceutical Co., Ltd. (SHA:603235)
China
· Delayed Price · Currency is CNY 26.35
-0.03 (-0.11%)
At close: Apr 29, 2026
SHA:603235 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Market Capitalization | 11,480 | 11,737 | 11,145 | 10,524 | 12,748 | - | Upgrade
|
| Market Cap Growth | -3.88% | 5.30% | 5.90% | -17.45% | - | - | Upgrade
|
| Enterprise Value | 10,315 | 10,583 | 9,508 | 8,230 | 12,181 | - | Upgrade
|
| Last Close Price | 26.38 | 26.97 | 24.94 | 22.99 | 27.17 | - | Upgrade
|
| PE Ratio | 19.54 | 19.84 | 17.11 | 22.12 | 20.49 | - | Upgrade
|
| PS Ratio | 4.90 | 5.01 | 5.05 | 5.59 | 5.53 | - | Upgrade
|
| PB Ratio | 2.33 | 2.39 | 2.42 | 2.49 | 3.14 | - | Upgrade
|
| P/TBV Ratio | 2.43 | 2.48 | 2.52 | 2.61 | 3.23 | - | Upgrade
|
| P/FCF Ratio | 235.82 | 241.09 | - | 54.36 | 36.83 | - | Upgrade
|
| P/OCF Ratio | 18.24 | 18.65 | 22.31 | 14.43 | 21.02 | - | Upgrade
|
| EV/Sales Ratio | 4.40 | 4.51 | 4.31 | 4.37 | 5.29 | - | Upgrade
|
| EV/EBITDA Ratio | 11.72 | 12.08 | 12.35 | 15.11 | 17.51 | - | Upgrade
|
| EV/EBIT Ratio | 14.96 | 15.35 | 15.36 | 20.13 | 21.29 | - | Upgrade
|
| EV/FCF Ratio | 211.89 | 217.40 | - | 42.51 | 35.19 | - | Upgrade
|
| Debt / Equity Ratio | 0.08 | 0.08 | 0.03 | 0.03 | 0.00 | 0.18 | Upgrade
|
| Debt / EBITDA Ratio | 0.46 | 0.46 | 0.19 | 0.20 | 0.01 | 0.36 | Upgrade
|
| Debt / FCF Ratio | 8.32 | 8.32 | - | 0.56 | 0.02 | 0.58 | Upgrade
|
| Net Debt / Equity Ratio | -0.24 | -0.24 | -0.31 | -0.52 | -0.56 | -0.19 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.33 | -1.33 | -1.83 | -4.04 | -3.29 | -0.38 | Upgrade
|
| Net Debt / FCF Ratio | -23.93 | -23.93 | 2.49 | -11.36 | -6.62 | -0.61 | Upgrade
|
| Asset Turnover | 0.40 | 0.40 | 0.41 | 0.39 | 0.60 | 0.86 | Upgrade
|
| Inventory Turnover | 2.33 | 2.33 | 2.41 | 2.47 | 3.31 | 3.89 | Upgrade
|
| Quick Ratio | 3.20 | 3.20 | 3.88 | 5.62 | 8.55 | 1.68 | Upgrade
|
| Current Ratio | 4.38 | 4.38 | 5.29 | 6.77 | 10.18 | 2.33 | Upgrade
|
| Return on Equity (ROE) | 12.41% | 12.41% | 14.72% | 11.48% | 20.85% | 48.56% | Upgrade
|
| Return on Assets (ROA) | 7.31% | 7.31% | 7.24% | 5.23% | 9.37% | 18.39% | Upgrade
|
| Return on Invested Capital (ROIC) | 15.68% | 16.64% | 19.94% | 18.12% | 29.64% | 72.55% | Upgrade
|
| Return on Capital Employed (ROCE) | 12.40% | 12.40% | 12.20% | 8.80% | 13.10% | 37.90% | Upgrade
|
| Earnings Yield | 5.15% | 5.04% | 5.84% | 4.52% | 4.88% | - | Upgrade
|
| FCF Yield | 0.42% | 0.41% | -5.09% | 1.84% | 2.71% | - | Upgrade
|
| Dividend Yield | 2.08% | - | 2.73% | 2.17% | 2.61% | - | Upgrade
|
| Payout Ratio | 51.53% | 51.53% | 33.81% | 65.66% | 1.10% | 118.09% | Upgrade
|
| Buyback Yield / Dilution | -0.26% | -0.26% | -0.11% | -5.96% | -4.68% | 0.10% | Upgrade
|
| Total Shareholder Return | 1.82% | -0.26% | 2.61% | -3.79% | -2.06% | 0.10% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.